Pacific Biosciences of California, Inc. (PACB) vs SS Innovations International, Inc. (SSII)
- Pacific Biosciences of California, Inc. PACB 1.73 −11.73%
- SS Innovations International, Inc. SSII 2.55 −1.16%
Pacific Biosciences of California, Inc. and SS Innovations International, Inc. are both Medical Devices companies. Pacific Biosciences of California, Inc. is the larger, with a market value of $609.2M against $517.2M — 1.2× the size. SS Innovations International, Inc. grew revenue faster over the last twelve months: 89.7% against 2.02%. SS Innovations International, Inc. has the higher net margin (−23.7% vs −82.5%) and the higher return on invested capital (−11.3% vs −22.2%). Across the 16 metrics below, SS Innovations International, Inc. leads on 11 and Pacific Biosciences of California, Inc. on 5.
Valuation
Profitability
| Metric | PACB | SSII | Medical Devices median |
|---|---|---|---|
| Gross margin | 36.38% | 47.65% | 56.01% |
| Operating margin | (83.53%) | (15.80%) | (15.03%) |
| Net margin | (82.49%) | (23.73%) | (20.40%) |
| Free cash flow margin | (50.53%) | (34.76%) | (7.24%) |
| Return on equity | (929.31%) | (26.06%) | (15.32%) |
| Return on assets | (16.66%) | (14.89%) | (19.72%) |
| Return on invested capital | (22.22%) | (11.31%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack